Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants

Poor graft function (PGF) is a fatal complication following allogeneic haematopoietic stem cell transplantation. However, the underlying mechanism is unclear. Effective cross-talk between haematopoietic stem cells (HSCs) and bone marrow microenvironment is important for normal haematopoiesis. Normal HSCs reside in a hypoxic bone marrow microenvironment that protects them from oxidative stress that would otherwise inhibit their self-renewal and results in bone marrow failure. Whether an increased level of reactive oxygen species (ROS) causes PGF following allotransplant is unclear. Using a prospective case-pair study, we identified increased levels of ROS in CD34(+) bone marrow cells in subjects with PGF. Elevated ROS levels was associated with an increased frequency of DNA strand breaks, apoptosis, exhaustion of quiescent CD34(+) cells and defective colony-forming unit plating efficiency, particularly in the CD34(+) CD38-fraction. Up-regulated intracellular p53, p21, caspase-3 and caspase-9 levels (but not p38) were detected in CD34(+) cells, particularly in the CD34(+) CD38-fraction. To further study the potential role of ROS levels in post-transplant haematopoiesis, CD34(+) bone marrow cells from subjects with good graft function were treated with H2O2. This increased ROS levels resulting in defective CD34(+) cells, an effect partially reversed by N-acetyl-L-cysteine. Moreover, CD34(+) bone marrow cells from the donors to subjects with poor or good graft function exhibited comparable haematopoietic reconstitution capacities in the xeno-transplanted NOD-Prkdc(scid)IL2rg(null) mice. Thus, even if the transplanted donors' bone marrow CD34(+) cells are functionally normal pre-transplant, ROS-induced apoptosis may contribute to the exhaustion of CD34(+) bone marrow cells in subjects with PGF following allotransplant.National Natural Science Foundation of China [81370638, 81570127, 81530046, 81230013]; Milstein Medical Asian American Partnership (MMAAP) Foundation; Beijing Municipal Science and Technology Program [Z151100004015164, Z151100001615020, Z141100000214011]; Science and Technology Project of Guangdong Province of ChinaSCI(E)PubMedARTICLExjhrm@medmail.com.cn2130892-30906